Eva Melander

1.8k total citations
41 papers, 1.4k citations indexed

About

Eva Melander is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Clinical Biochemistry. According to data from OpenAlex, Eva Melander has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 14 papers in Applied Microbiology and Biotechnology and 9 papers in Clinical Biochemistry. Recurrent topics in Eva Melander's work include Pneumonia and Respiratory Infections (18 papers), Antibiotic Use and Resistance (14 papers) and Urinary Tract Infections Management (9 papers). Eva Melander is often cited by papers focused on Pneumonia and Respiratory Infections (18 papers), Antibiotic Use and Resistance (14 papers) and Urinary Tract Infections Management (9 papers). Eva Melander collaborates with scholars based in Sweden, Denmark and Qatar. Eva Melander's co-authors include Sigvard Mölstad, Karl Ekdahl, Inga Odenholt, Mats Walder, Johan Tham, Kristina Persson, Håkan Ringberg, Katarina Hedin, Anders Beckman and Jonas Ahl and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Eva Melander

39 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Eva Melander 769 414 341 219 199 41 1.4k
Berit Müller‐Pebody 876 1.1× 425 1.0× 406 1.2× 400 1.8× 358 1.8× 68 1.9k
Cees M. Verduin 637 0.8× 425 1.0× 203 0.6× 272 1.2× 75 0.4× 30 1.3k
Léonardo Pagani 474 0.6× 400 1.0× 280 0.8× 401 1.8× 122 0.6× 68 1.7k
Angela Dramowski 543 0.7× 327 0.8× 260 0.8× 400 1.8× 464 2.3× 105 1.5k
Jadwiga Wójkowska‐Mach 340 0.4× 202 0.5× 303 0.9× 355 1.6× 210 1.1× 155 1.3k
Hsieh‐Shong Leu 554 0.7× 193 0.5× 402 1.2× 407 1.9× 148 0.7× 44 1.4k
Shmuel Benenson 376 0.5× 189 0.5× 350 1.0× 421 1.9× 202 1.0× 77 1.3k
Stephanie H. Factor 864 1.1× 232 0.6× 712 2.1× 456 2.1× 421 2.1× 47 2.2k
Sujan Reddy 377 0.5× 296 0.7× 306 0.9× 561 2.6× 130 0.7× 62 1.7k
Olga Perovic 432 0.6× 497 1.2× 563 1.7× 452 2.1× 285 1.4× 89 1.5k

Countries citing papers authored by Eva Melander

Since Specialization
Citations

This map shows the geographic impact of Eva Melander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Melander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Melander more than expected).

Fields of papers citing papers by Eva Melander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Melander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Melander. The network helps show where Eva Melander may publish in the future.

Co-authorship network of co-authors of Eva Melander

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Melander. A scholar is included among the top collaborators of Eva Melander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Melander. Eva Melander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Hedin, Katarina, et al.. (2019). Increased adherence to treatment guidelines in patients with urinary tract infection in primary care: A retrospective study. PLoS ONE. 14(3). e0214572–e0214572. 17 indexed citations
4.
5.
Lindgren, A., et al.. (2016). Methicillin-resistant Staphylococcus aureus with mecC: a description of 45 human cases in southern Sweden. European Journal of Clinical Microbiology & Infectious Diseases. 35(6). 971–975. 10 indexed citations
6.
Beckman, Anders, Sigvard Mölstad, Sven Engström, et al.. (2016). Reduction in antibiotic prescribing for respiratory tract infections in Swedish primary care- a retrospective study of electronic patient records. BMC Infectious Diseases. 16(1). 709–709. 57 indexed citations
7.
Melander, Eva, et al.. (2014). Efficacy of a once-a-week screening programme to control extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit. Scandinavian Journal of Infectious Diseases. 46(6). 426–432. 12 indexed citations
8.
Tham, Johan, Inga Odenholt, Mats Walder, Eva Melander, & Lina Andersson. (2013). Risk factors for infections with extended- spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden. Infection and Drug Resistance. 6. 93–93. 28 indexed citations
9.
Larsson, Anna‐Karin, et al.. (2013). Epidemiology of MRSA in southern Sweden: strong relation to foreign country of origin, health care abroad and foreign travel. European Journal of Clinical Microbiology & Infectious Diseases. 33(1). 61–68. 25 indexed citations
10.
Ahl, Jonas, et al.. (2013). Risk Factors for Pneumococcal Carriage in Day Care Centers. The Pediatric Infectious Disease Journal. 33(5). 536–538. 4 indexed citations
11.
Tham, Johan, Mats Walder, Eva Melander, & Inga Odenholt. (2012). Duration of colonization with extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea. Scandinavian Journal of Infectious Diseases. 44(8). 573–577. 39 indexed citations
12.
Larsson, Anna‐Karin, et al.. (2011). Duration of methicillin-resistant Staphylococcus aureus colonization after diagnosis: A four-year experience from southern Sweden. Scandinavian Journal of Infectious Diseases. 43(6-7). 456–462. 31 indexed citations
13.
Tham, Johan, Inga Odenholt, Mats Walder, et al.. (2010). Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea. Scandinavian Journal of Infectious Diseases. 42(4). 275–280. 90 indexed citations
14.
Ahl, Jonas, Johan Tham, Mats Walder, Eva Melander, & Inga Odenholt. (2010). Bacterial aetiology in ventilator-associated pneumonia at a Swedish university hospital. Scandinavian Journal of Infectious Diseases. 42(6-7). 469–474. 7 indexed citations
15.
Högberg, Liselotte Diaz, Karl Ekdahl, Karin Sjöström, et al.. (2006). Penicillin-Resistant Pneumococci in Sweden 1997–2003: Increased Multiresistance Despite Stable Prevalence and Decreased Antibiotic Use. Microbial Drug Resistance. 12(1). 16–22. 16 indexed citations
16.
Melander, Eva, Juan Merlo, Jens P. Kampmann, et al.. (2003). Utilisation of antibiotics in young children: opposite relationships to adult educational levels in Danish and Swedish counties. European Journal of Clinical Pharmacology. 59(4). 331–335. 17 indexed citations
17.
Melander, Eva, et al.. (2000). Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. The Pediatric Infectious Disease Journal. 19(12). 1172–1177. 85 indexed citations
18.
Melander, Eva, Sigvard Mölstad, Jonas Ranstam, et al.. (1998). Intra-urban variation of antibiotic utilization in children: influence of socio-economic factors. European Journal of Clinical Pharmacology. 54(8). 653–657. 25 indexed citations
19.
Melander, Eva, Sigvard Mölstad, Kristina Persson, et al.. (1998). Previous Antibiotic Consumption and Other Risk Factors for Carriage of Penicillin-Resistant Streptococcus pneumoniae in Children. European Journal of Clinical Microbiology & Infectious Diseases. 17(12). 834–838. 87 indexed citations
20.
Ekdahl, Karl, Hans Bertil Hansson, Eva Melander, et al.. (1997). Duration of Nasopharyngeal Carriage of Penicillin‐ResistantStreptococcus pneumoniae: Experiences from the South Swedish Pneumococcal Intervention Project. Clinical Infectious Diseases. 25(5). 1113–1117. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Berit Müller‐Pebody Breakdown of academic impact, for papers by Cees M. Verduin Breakdown of academic impact, for papers by Léonardo Pagani Breakdown of academic impact, for papers by Angela Dramowski Breakdown of academic impact, for papers by Jadwiga Wójkowska‐Mach Breakdown of academic impact, for papers by Hsieh‐Shong Leu Breakdown of academic impact, for papers by Shmuel Benenson Breakdown of academic impact, for papers by Stephanie H. Factor Breakdown of academic impact, for papers by Sujan Reddy Breakdown of academic impact, for papers by Olga Perovic
Rankless by CCL
2026